Download PDF
Exp Clin Endocrinol Diabetes 2003; 111(7): 415-420
DOI: 10.1055/s-2003-44288
Article

J. A. Barth Verlag in Georg Thieme Verlag Stuttgart · New York

Adrenocortical Tumors: Prevalence of Impaired Glucose Tolerance and of “Paradoxical Rise” of Cortisol During an Oral Glucose Tolerance Test

H. Vierhapper 1 , G. Heinze 2 , A. Gessl 1 , M. Exner 3
  • 1Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine III, University of Vienna, Vienna, Austria
  • 2Institute for Medical Computer Sciences, University of Vienna, Vienna, Austria
  • 3Institute of Medical and Chemical Laboratory Diagnostics, University of Vienna, Vienna, Austria
Further Information

Publication History

Received: September 20, 2002 First decision: October 20, 2002

Accepted: February 24, 2003

Publication Date:
13 November 2003 (online)

Also available at
    Permissions and Reprints

Abstract

Glucose tolerance and the behaviour of cortisol during an oral glucose tolerance test (OGTT) was investigated in 126 patients with adrenal “incidentalomas” (age: > 45 years) and in 129 age-matched controls. Impaired glucose tolerance (IGT) was found to be more common (p < 0.02) among patients with adrenal incidentalomas. Subdividing these patients by their body weight it was found that 29 % (controls: 25 %) of those with normal body weight (BMI 20 - 25 kg/m2) had IGT/DM. In overweight (BMI 25 - 30 kg/m2) and obese patients (BMI 30 - 40 kg/m2) the share of IGT/DM was 32 % (controls: 19 %) and 66 % (controls 42 %), respectively. The prevalence of a “paradoxical” rise in serum cortisol concentrations during the OGTT was slightly higher (p < 0.05) among patients with adrenal incidentaloma than among controls. Patients as well as controls with this abnormal behaviour of cortisol were characterized by lower basal serum cortisol concentrations (p < 0.01) but no association was seen with either the presence of IGT or with post-dexamethasone concentrations of serum cortisol. Thus both in patients with and without adrenal incidentalomas abnormal glucose tolerance is an age- and weight-dependent phenomenon unrelated to the post-prandial behaviour of serum cortisol concentrations.

Key words

Adrenal incidentaloma - adrenal adenoma - impaired glucose tolerance - cortisol - age - body weight

References

  • 1 Anderson W A, Kissane J M. Pathology. ed 7. St. Louis; Mosby 1977: 1671-1674
    Google Scholar
  • 2 Andres R. Aging and diabetes.  Med Clin North Amer. 1991;  55 835-846
    PubMedGoogle Scholar
  • 3 Andrews R C, Walker B R. Glucocorticoids and insulin resistance: old hormones, new targets.  Clin Sci. 1999;  96 513-523
    CrossrefPubMedGoogle Scholar
  • 4 Baumgartner-Parzer S M, Pauschenwein S, Waldhäusl W, Pölzler K, Nowotny P, Vierhapper H. Increased prevalence of heterozygous 21-OH germ line mutations in patients with adrenal incidentalomas.  Clin Endocrinol. 2002;  56 811-816
    CrossrefPubMedGoogle Scholar
  • 5 Beuschlein F, Borgemeister M, Schirra J, Goke B, Fassnacht M, Arlt W, Allolio B, Reincke M. Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper-responsiveness of hypothalamo-pituitary-adrenal axis in patients with adrenal incidentalomas.  Clin Endocrinol. 2000;  52 617-623
    CrossrefPubMedGoogle Scholar
  • 6 Biermann E L, Bagdale J D, Porte D. Obesity and diabetes: the odd couple.  Am J Clin Nutr. 1968;  21 1434-1437
    PubMedGoogle Scholar
  • 7 Björntorp P. Visceral obesity: “a civilisation syndrome”.  Obes Res. 1993;  1 206-222
    PubMedGoogle Scholar
  • 8 Dinnen S, Alzaid A, Miles J, Rizza R. Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.  J Clin Invest. 1993;  92 2283-2290
    PubMedGoogle Scholar
  • 9 Everhart J E, Pettitt D J, Bennett P H, Knowler W C. Duration of obesity increases the incidence of NIDDM.  Diabetes. 1992;  42 235-240
    PubMedGoogle Scholar
  • 10 Fernandez-Real J M, Engel W R, Simo R, Salinas I, Webb S M. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours.  Clin Endocrinol. 1998;  49 53-61
    CrossrefPubMedGoogle Scholar
  • 11 Fruehwald-Schultes B, Kern W, Bong W, Wellhoener P, Kerner W, Born J, Fehm H L, Peters A. Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans.  J Clin Endocrinol Metab. 1999;  84 3041-3046
    CrossrefPubMedGoogle Scholar
  • 12 Garrapa G G, Pantanetti P, Arnaldi G, Mantero F, Faloia E. Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome.  J Clin Endocrinol Metab. 2001;  86 5301-5306
    CrossrefPubMedGoogle Scholar
  • 13 Harris M I, Hadden W C, Knowler W C, Bennet P H. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20 - 74 yr.  Diabetes. 1987;  36 523-534
    CrossrefPubMedGoogle Scholar
  • 14 Hedeland H, Ostberg G, Hokfeld B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes.  Acta Med Scand. 1968;  184 211-214
    PubMedGoogle Scholar
  • 15 Hosmer D W, Lemeshow S. Applied Logistic Regression. New York; Wiley 1989
    Google Scholar
  • 16 Jarrett R J, McCartney P, Keen H. The Bedford Survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics.  Diabetologia. 1982;  22 79-84
    PubMedGoogle Scholar
  • 17 Korbonits M, Trainer P, Nelson M, Howse I, Kopelman P, Besser G, Grossman A, Svec F. Differential stimulation of cortisol and dehydroepiandrosterone levels by food in obese and normal subjects: relation to body fat distribution.  Clin Endocrinol (Oxf). 1996;  45 699-706
    CrossrefPubMedGoogle Scholar
  • 18 Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
    Google Scholar
  • 19 Mesiano S, Mellon S H, Jaffe R B. Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland.  J Clin Endocrinol Metab. 1993;  76 968-976
    CrossrefPubMedGoogle Scholar
  • 20 Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection.  Clin Endocrinol. 2001;  54 797-804
    CrossrefPubMedGoogle Scholar
  • 21 Reincke M, Nieke J, Krestin G P, Saeger W, Allolio B, Winkelmann W. Preclinical Cushing's Syndrome in adrenal “incidentalomas”: comparison with adrenal Cushing's syndrome.  J Clin Endocrinol Metab. 1992;  75 826-832
    CrossrefPubMedGoogle Scholar
  • 22 Reincke M, Faßnacht M, Väth S, Mora P, Allolio B. Adrenal incidentalomas: a manifestation of the metabolic syndrome?.  Endocr Res. 1996;  22 757-761
    PubMedGoogle Scholar
  • 23 Ross N S, Aron D C. Hormonal evaluation of the patient with an incidentally discovered adrenal mass.  N Engl J Med. 1990;  323 1402-1405
    PubMedGoogle Scholar
  • 24 Ross N S. Epidemiology of Cushing's syndrome and subclinical disease.  Endocrinol Metab North Am. 1994;  23 539-546
    PubMedGoogle Scholar
  • 25 Rossi R, Tauchmanova L, Luciano A, Dimartino M, Battista C, Delviscovo L, Nuzzo V, Lombardi G. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: Clinical and biochemical features.  J Clin Endocrinol Metab. 2000;  85 1440-1448
    CrossrefPubMedGoogle Scholar
  • 26 Russi S, Blumenthal H T. Small adenomas of the adrenal cortex in hypertension and diabetes.  Arch Intern Med. 1945;  76 284-291
    PubMedGoogle Scholar
  • 27 Saad M F, Knowler W C, Pettitt D J, Nelson R G, Mott D M, Bennett P H. The natural history of impaired glucose tolerance in the Pima Indians.  New Engl J Med. 1988;  319 1500-1506
    PubMedGoogle Scholar
  • 28 Sluiter W J, Erkelens D W, Reitsma W D, Doorenbos H. Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading.  Diabetes. 1976;  25 241-244
    PubMedGoogle Scholar
  • 29 Terzolo M, Pia A, Ali A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A. Adrenal incidentaloma: A new cause of the metabolic syndrome?.  J Clin Endocrinol Metab. 2002;  87 998-1003
    CrossrefPubMedGoogle Scholar
  • 30 Vierhapper H. Adrenocortical tumors: clinical symptoms and biochemical diagnosis.  Europ J Radiol. 2002;  41 88-94
    PubMedGoogle Scholar
  • 31 Waldhäusl W, Herkner K, Nowotny P, Bratusch-Marrain P. Combined 17α- and 18-hydroxylase deficiency associated with complete male pseudohermaphroditism and hypoaldosteronism.  J Clin Endocrinol Metab. 1978;  46 236-246
    PubMedGoogle Scholar
  • 32 Waldhäusl W, Kleinberger G, Korn A, Dudczak R, Bratusch-Marrain P, Nowotny P. Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration.  Diabetes. 1979;  28 577-584
    PubMedGoogle Scholar
  • 33 World Health Organization Study Group .Diabetes Mellitus. WHO Technical Report Series 727. Geneva, Switzerland; World Health Organization 1985
    Google Scholar
  • 34 Young W F. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota.  Endocr Metab Clin North Am. 2000;  29 159-185
    CrossrefPubMedGoogle Scholar

M. D. H. Vierhapper

Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine III
University of Vienna

Währinger Gürtel 18 - 20

1090 Wien

Austria

Phone: +43(1)404004348

Fax: + 43 (1) 4 04 00 62 10

Email: h.vierhapper@akh-wien.ac.at

      >